These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16949379)

  • 1. High-risk situations and procedures.
    Becker CR; Davidson C; Lameire N; McCullough PA; Stacul F; Tumlin J; Adam A;
    Am J Cardiol; 2006 Sep; 98(6A):37K-41K. PubMed ID: 16949379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and prognostic implications of contrast-induced nephropathy.
    McCullough PA; Adam A; Becker CR; Davidson C; Lameire N; Stacul F; Tumlin J;
    Am J Cardiol; 2006 Sep; 98(6A):5K-13K. PubMed ID: 16949375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast medium use.
    Davidson C; Stacul F; McCullough PA; Tumlin J; Adam A; Lameire N; Becker CR;
    Am J Cardiol; 2006 Sep; 98(6A):42K-58K. PubMed ID: 16949380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk prediction of contrast-induced nephropathy.
    McCullough PA; Adam A; Becker CR; Davidson C; Lameire N; Stacul F; Tumlin J;
    Am J Cardiol; 2006 Sep; 98(6A):27K-36K. PubMed ID: 16949378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to reduce the risk of contrast-induced nephropathy.
    Stacul F; Adam A; Becker CR; Davidson C; Lameire N; McCullough PA; Tumlin J;
    Am J Cardiol; 2006 Sep; 98(6A):59K-77K. PubMed ID: 16949381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
    Cavusoglu E; Chhabra S; Marmur JD; Kini A; Sharma SK
    Minerva Cardioangiol; 2004 Oct; 52(5):419-32. PubMed ID: 15514576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline renal function screening.
    Lameire N; Adam A; Becker CR; Davidson C; McCullough PA; Stacul F; Tumlin J;
    Am J Cardiol; 2006 Sep; 98(6A):21K-26K. PubMed ID: 16949377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.
    McCullough P
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):335-43. PubMed ID: 16489569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
    Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention.
    Seyon RA; Jensen LA; Ferguson IA; Williams RG
    Heart Lung; 2007; 36(3):195-204. PubMed ID: 17509426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency.
    La Manna G; Pancaldi L; Dalmastri V; Cuna V; Capecchi A; Comai G; Persici E; Bacchi G; Cianciolo G; Lombardi A; Marrozzini C; Colì L; Stefoni S
    In Vivo; 2008; 22(1):123-9. PubMed ID: 18396794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
    Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
    Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
    Nyman U; Björk J; Aspelin P; Marenzi G
    Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of contrast-induced nephropathy.
    McCullough PA; Sandberg KR
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S3-9. PubMed ID: 14668704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
    Fishman EK; Reddan D
    Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-induced nephropathy.
    Pucelikova T; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):62-72. PubMed ID: 17975790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of contrast-induced nephropathy.
    Tumlin J; Stacul F; Adam A; Becker CR; Davidson C; Lameire N; McCullough PA;
    Am J Cardiol; 2006 Sep; 98(6A):14K-20K. PubMed ID: 16949376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and treatment of contrast-induced nephropathy.
    Al-Ghonaim M; Pannu N
    Tech Vasc Interv Radiol; 2006 Jun; 9(2):42-9. PubMed ID: 17482099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of contrast-induced nephropathy and management of high-risk patients].
    Marenzi G
    G Ital Cardiol (Rome); 2009 Feb; 10(2):88-96. PubMed ID: 19348145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.